PositiveID announced it has entered into an agreement with Siemens related to its Wireless Body platform, an integrated, internal and external, smart health care communication system that has the ability to deliver personalized medical solutions wirelessly.
The license agreement grants PositiveID rights to utilize key intellectual property and Siemens’ patent titled “Method and System for Identification of a Medical Implant” using RFID.
By establishing this agreement PositiveID will expand its personalized medicine and smart health care applications for patient monitoring and overall wellness through the identification of implantable medical devices within the body.
The Wireless Body platform is designed to enhance wellness and disease management for diabetes and other chronic illnesses by allowing health care systems to communicate with each other and monitor patients. In addition, the platform has the ability to identify medical devices, currently catheter ports, to allow them to communicate with an external reader to ensure proper medication dosages and safety for the patient.